Recombinant Human PLA2G12B Protein，His

PLA2G12B, a member of the phospholipase A2 (PLA2) enzyme family, has gained significant attention due to its potential roles in various physiological and pathological processes. Phospholipases are known to hydrolyze phospholipids, leading to the release of free fatty acids and lysophospholipids, which are crucial for cell signaling, membrane dynamics, and inflammatory responses. PLA2G12B, in particular, is suggested to play a role in lipid metabolism, immune regulation, and even cancer progression. Its expression pattern and functional implications in different tissues highlight its importance in cellular homeostasis and disease mechanisms. Recent studies indicate that PLA2G12B may be involved in modulating inflammatory pathways, thus contributing to autoimmunity and other inflammatory disorders. Understanding the biochemical properties and regulatory mechanisms of PLA2G12B is essential for elucidating its biological functions and potential therapeutic applications. To further investigate this enzyme, researchers frequently utilize recombinant protein technology to produce and study the PLA2G12B protein in controlled experimental settings. This enables detailed analysis of its enzymatic activity, substrate specificity, and interaction with inhibitors or other biomolecules. Consequently, the characterization of PLA2G12B and its associated pathways could pave the way for novel strategies in targeted therapies for diseases where phospholipid metabolism is disrupted. As research continues to unveil the multifaceted roles of PLA2G12B, it remains a promising target for future studies aiming to develop innovative interventions in inflammation and cancer treatment.